Jump Financial’s Sutro Biopharma STRO Stock Holding History

Jump Financial’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$309K	Buy	+12,385	New	+$224K	﹤0.01%	1469
2024 Q2	–	Sell	-11,120	Closed	-$628K	–	2239
2024 Q1	$628K	Buy	+11,120	New	+$491K	0.02%	1054
2023 Q1	–	Sell	-4,260	Closed	-$344K	–	2043
2022 Q4	$344K	Sell	4,260 -330	-7%	-$22.9K	0.02%	962
2022 Q3	$255K	Buy	+4,590	New	+$272K	0.01%	1227
2022 Q2	–	Sell	-3,280	Closed	-$270K	–	2005
2022 Q1	$270K	Buy	+3,280	New	+$312K	0.01%	1126
2021 Q1	–	Sell	-2,069	Closed	-$449K	–	1264
2020 Q4	$449K	Buy	+2,069	New	+$343K	0.08%	415

Other funds holding STRO

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Jump Financial's STRO Position: Q1 2026 in Review

Jump Financial opened a new position in Sutro Biopharma (STRO) in Q1 2026: 12,385 shares worth $309K. The stake represents ﹤0.01% of the portfolio and ranks #1469 among its holdings. This is a return to the name: Jump Financial previously reported a position in STRO as recently as Q1 2024.

Jump Financial first reported a position in STRO in Q4 2020 and has held it in 6 quarters since. The position peaked at $628K in Q1 2024. 78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

Jump Financial held 12,385 shares of Sutro Biopharma worth $309K as of Q1 2026.
Sutro Biopharma was a new Jump Financial position in Q1 2026.
Sutro Biopharma made up ﹤0.01% of Jump Financial's portfolio in Q1 2026, its #1469 holding.
Jump Financial first reported a position in Sutro Biopharma in Q4 2020 and has held it in 6 quarters since.
Jump Financial's Sutro Biopharma position peaked at $628K in Q1 2024.
78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.